| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |